Clearside Biomedical Inc. (CLSD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clearside Biomedical Inc.

    NASDAQ: CLSD · Real-Time Price · USD
    0.50
    -0.04 (-7.20%)
    At close: Jul 25, 2025, 3:59 PM

    Clearside Biomedical Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.04 -2.23 -1.98 427.80
    PEG Ratio
    		 0.18 0.32 0.00 -4.21
    PS Ratio
    		 42.14 8.79 50.81 5.44
    PB Ratio
    		 -1.8 -4.54 6.36 4.24
    P/FCF Ratio
    		 -2.73 -3.63 -4.95 -14.99
    P/OCF Ratio
    		 -2.84 -3.99 -5.05 -14.99
    OCF/S Ratio
    		 -14.84 -2.2 -10.07 -0.36
    Debt / Equity Ratio
    		 -0.02 -2.7 0.12 0.02
    Quick Ratio
    		 4.44 4.42 8.34 8.88
    Current Ratio
    		 4.44 4.42 8.34 9.08
    Asset Turnover
    		 0.07 0.24 0.03 0.69
    Interest Coverage
    		 -2.95 -2.65 -9.07 n/a
    Return on Equity
    		 0.88 2.04 -3.21 0.01
    Return on Assets
    		 -1.37 -0.95 -0.66 0.01
    Return on Invested Capital
    		 -1.37 -0.9 -0.68 -0.02
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.91 0.96 0.85 0.99
    Net Profit Margin
    		 -20.64 -3.95 -25.68 0.01
    Pretax Profit Margin
    		 -20.64 -3.95 -24.83 0.01
    Operating Profit Margin
    		 -17.36 -3.02 -22.82 -0.02
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -14.63 -2.8 -22.2 -0.02

    Add to Watchlist